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Abstract:  
RNA promotes liquid-liquid phase separation (LLPS) to build membrane-less compartments in 
cells. How distinct molecular compositions are established and maintained in these liquid 
compartments is unknown. Here we report that secondary structure allows mRNAs to self-
associate and determines if an mRNA is recruited to or excluded from liquid compartments.  The 
polyQ-protein Whi3 induces conformational changes in RNA structure and generates distinct 
molecular fluctuations depending on the RNA sequence.  These data support a model in which 
structure-based, RNA-RNA interactions promote assembly of distinct droplets and protein-driven, 
conformational dynamics of the RNA maintain this identity. Thus, the shape of RNA can promote 
the formation and coexistence of the diverse array of RNA-rich liquid compartments found in a 
single cell.   
 
One Sentence Summary:  
Identity in cellular, phase-separated compartments arises from RNA-RNA complexes encoded by 
mRNA secondary structures.  
 
Main Text:  
Formation of non-membrane bound organelles through the condensation of macromolecules is a 
recently appreciated mechanism of intracellular organization. These liquid-like condensates form 
through liquid-liquid phase separation (LLPS) and are found in the cytoplasm and nucleus (1, 2). 
A fundamental unsolved problem is how liquid droplets recruit distinct constituents and retain 
independent identities. RNA can drive LLPS and modulates the material properties of droplets (3-
6), but it is unknown if RNA controls the identity and maintenance of coexisting liquid 
compartments. Here we show mRNA secondary structure is required for droplet identity through 
directing interactions between mRNAs and RNA-binding proteins.  
 
Whi3, a polyQ-containing, RNA-binding protein first identified in Saccharomyces cerevisiae (7), 
functions in morphogenesis, memory of mating, and stress responses, where it forms aggregates 
and associates with RNA-processing bodies (8-11). The homolog in the filamentous fungus 
Ashbya gossypii has one RNA recognition motif (RRM) and an expanded polyQ tract (Fig. S1A), 
and both regions promote self-assembly. In vitro, Whi3 polyQ-dependent LLPS is driven by 
specific RNAs encoding regulators of either the cell cycle (e.g. the cyclin CLN3) or actin (e.g. the 
formin BNI1 and SPA2) (3). Distinct types of Whi3 droplets form in Ashbya cells: perinuclear 
CLN3 droplets and BNI1 droplets at sites of polarized growth at cell tips ((12, 13), Fig. 1A and 
movie S1). These two types of droplets have different Whi3 levels and Whi3 incorporation rates 
(Fig. 1, B and C), suggesting they are structurally distinct. 
 
The distinct droplet properties may depend on extrinsic features of the local cytosolic 
microenvironment or arise due to different droplet constituents. CLN3 and BNI1 mRNAs 
minimally co-localize in the cytoplasm by single molecule (sm) RNA F.I.S.H., although they were 
occasionally co-expressed by the same nucleus (Fig. 1, D and F). The lack of co-localization 
suggests there are intrinsic, compositional differences between droplets. In contrast, mRNA of the 
polarity regulator SPA2, frequently co-localized with BNI1 mRNAs, especially at growth sites 
(Fig. 1, E and F). Thus, mRNAs encoding functionally related proteins co-localize, while 
functionally unrelated mRNAs do not. How can distinct Whi3-binding mRNAs segregate to 
different droplets in a common cytoplasm? 
 To address this question, we employed a reconstitution system to test if mRNA sequence was 
sufficient to generate droplet individuality (Fig. 2A). In vitro, as in cells, droplets composed of 
BNI1 mRNA displayed higher Whi3 to RNA molar ratios than droplets made with CLN3 mRNA 
(Fig. S1B). Remarkably, when CLN3 mRNA was added to Whi3 droplets made with BNI1 mRNA, 
CLN3 preferentially assembled into new droplets, rather than incorporating into BNI1 droplets 
(Fig. 2, B and C, S1C). In contrast, BNI1 mRNA readily incorporated into preformed droplets (Fig. 
2, B and C). Notably, SPA2 mRNA incorporated into BNI1 droplets (Fig. 2, B and C), and CLN3 
did not incorporate into SPA2 droplets (Fig. S1D). Thus, as in cells, cyclin and polarity mRNAs 
assemble into distinct and immiscible droplets in vitro, indicating droplet identity is encoded by 
the mRNA.  
 
mRNA sequences could influence droplet identity by favoring homotypic or specific heterotypic 
interactions between RNA molecules. To test for specific RNA-RNA interactions, we used a 
protein-free system to induce electrostatic-mediated phase transitions of the mRNA (14), where 
all mRNAs were capable of homotypic assembly into liquid or gel-like droplets (Fig. 2D). 
Strikingly, CLN3 mRNAs had minimal co-localization with BNI1 or SPA2 mRNAs, whereas BNI1 
and SPA2 were significantly more co-localized (Fig. 2 E–G). Thus, sequence-encoded features of 
the mRNA can underpin the assembly of distinct, immiscible structures. 
 
We next investigated which features of the mRNA sequence generate specificity. An mRNA with 
scrambled CLN3 coding sequence (cln3 scr) with intact Whi3-binding sites formed Whi3 droplets 
(Fig. S1E), but no longer showed specificity (Fig. 3, A and C). As the length, nucleotide 
composition, and Whi3 binding sites were identical, we hypothesized the secondary structure 
could promote specificity. CLN3 mRNA heated to 95ºC to disrupt secondary structure also readily 
incorporated into Whi3-BNI1 droplets (Fig. 3, A and C). Melted CLN3 mRNA that was slowly 
refolded (CLN3 refold) showed significantly less recruitment than melted, but more than native 
CLN3 (Fig. 3A and C). Mixing between melted CLN3 and melted BNI1 occurred in the presence 
of Whi3 and in RNA-only reactions, suggesting mixing is initiated by RNA-RNA interactions 
(Fig. S2). Thus, specificity information in CLN3 mRNA can be eliminated by disrupting secondary 
structure. 
 
To identify what features of CLN3 mRNA secondary structure promote specificity, we performed 
SHAPE-MaP, which identifies highly flexible regions in RNA (15), to determine secondary 
structure changes, on native, refolded, and scrambled CLN3 mRNA (Fig. 3D, S3A and B). The 
first 400 nucleotides in the CLN3 sequence exhibited especially low SHAPE reactivity (Fig. S3C, 
purple shaded regions), suggesting many paired nucleotides and a highly folded structure. 
Refolded CLN3 had a significant increase in SHAPE reactivity compared to native CLN3 (Fig. 
S3A, p <0.001, Wilcoxon rank sum test), indicating a transition to a more unstructured state (Fig 
3D and E). Melting and refolding thus allows the RNA to sample different conformations from 
those formed during transcription. As expected, cln3 scr showed a different SHAPE profile with 
dramatically altered secondary structure (Fig. 3 D and E, S3B). 
 
We hypothesized secondary structure influences mRNA sorting, as stem-loops may selectively 
display or mask sequences capable of hybridizing with other RNAs. CLN3 contains five 
complementary regions to BNI1 (Fig. S4A), most of which had low SHAPE reactivity and 
therefore were more structured (Fig. S4B), suggesting these regions are inaccessible for 
hybridizing with BNI1. We hypothesize these regions became available to pair with BNI1 when 
CLN3 is melted, causing the structure-dependent loss of droplet specificity. To test this hypothesis, 
oligonucleotides (i.e., oligos) complementary to these regions were added to melted CLN3 and 
significantly decreased the co-assembly with BNI1, restoring the formation of distinct CLN3 
droplets (Fig 3B and C). Additionally, cln3sm, a mutant perturbing structure and exposing 
complementarity, co-localized with BNI1 transcripts in vitro and at polarity sites in cells (Fig. 3F, 
S5, >60% tips co-localized). Thus, secondary structure can regulate RNA sorting into distinct 
droplets through altering the capacity to form intermolecular interactions. 
 
We next asked if exposed complementarity explains co-assembly of BNI1 and SPA2 into the 
same droplets. Indeed, SHAPE-MaP analysis of BNI1 and SPA2 showed complementary regions 
between these co-localizing mRNAs having significantly higher SHAPE reactivity and less 
structure compared to the CLN3/BNI1 regions (Fig S4 and S6; p < 0.002, t test). Addition of 
complementary oligos to these regions disrupted co-localization in the presence of Whi3 and in 
RNA-only reactions (Fig. S7 A and B). We predicted that CLN3 may self-assemble and indeed 
cln3 codon, a CLN3 mutant whose codons have been randomized but Whi3 binding sites remain 
intact, does not co-localize with endogenous CLN3 mRNA in cells, further supporting RNA-
RNA interactions in co-assembly of related RNAs (Fig S7C). These data suggest RNA-RNA 
interactions based on intermolecular hybridization direct RNAs into the same or different 
droplets. 
 
Does Whi3 protein influence the identity of droplets? The majority of Whi3 binding sites are 
exposed on stem loops in CLN3, BNI1, and SPA2 (Fig. 3E, S8 and S9). Notably, refolding or 
scrambling the CLN3 sequence rearranges the presentation of Whi3 binding sites (Fig. 3E).  
Therefore, RNA secondary structure may influence Whi3 binding and contribute to droplet 
composition and immiscibility in addition to RNA complexing. SHAPE-MaP of CLN3 mRNA in 
the presence of Whi3 support that Whi3 binding sites are occupied by protein (Fig. 4A, S10A) and 
revealed that protein binding causes structural rearrangements (Fig. 4B). We therefore hypothesize 
Whi3 binding may have important contributions to structural rearrangements of target RNAs 
relevant to droplet identity. 
 
To examine the consequence of Whi3 binding to RNA, we used smFRET (Fig. 4C) to measure the 
conformational dynamics of CLN3 and BNI1 mRNAs with and without Whi3 (16). In the absence 
of protein, CLN3 RNA showed high FRET values indicative of a compacted state, while BNI1 
RNA showed lower FRET values, indicating a less compact state (Fig. 4D, purple shaded regions). 
Upon addition of Whi3, CLN3 FRET values decreased, indicating more extended RNA 
conformations were induced, dependent on the ability of Whi3 to bind mRNA (Fig S10 B and C). 
In contrast, bound to Whi3, BNI1 RNA showed a more substantial broadening of FRET values 
(Fig. 4D), indicating Whi3-BNI1 complexes are more dynamic. Dwell-time analysis revealed 
Whi3-induced dynamics are three times faster for BNI1 than CLN3 (Fig. 4E). Different mRNAs 
thus react differentially in their intramolecular fluctuations to the presence of Whi3, providing an 
additional mode of RNA droplet regulation. 
 
These FRET studies suggest Whi3 binding alters the conformational dynamics of target RNAs. 
We speculate these differential dynamics help maintain droplet identities established by RNA-
RNA interactions. Once RNA-RNA interactions are formed, Whi3 binding may reduce the ability 
of the RNA to resample many alternate RNA structures to maintain the identity.  Additionally, the 
slower fluctuations of CLN3 bound to Whi3 may be one source of exclusion from the more rapidly 
fluctuating BNI1-Whi3 complexes in those droplets.  Such dynamics may drive the droplet 
material properties reported previously (3) and serve as barriers to homogenization.  
 
We show mRNA structure defines the ability of an RNA to engage in homo- or heteromeric 
interactions and thus drives specificity in the composition of liquid droplet compartments. This 
mechanism is likely relevant for the sorting of specific RNAs to other RNA-granules such as stress 
and P granules, and P-bodies (17, 18). Future work will address the timing and location of how 
mRNA secondary structure influences selective uptake of cellular constituents into droplets. 
Protein binding to different RNAs can lead to varied dynamics of complexes, further 
distinguishing the physical properties of different droplets and promoting immiscibility of 
coexisting droplets (Fig. 4F). Given the large number of distinct, RNA-based condensates in the 
cell, these mechanisms are likely broadly relevant to explain how droplets achieve and maintain 
individuality. 
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Figure 1. Cyclin and Polarity complexes are spatially and physically distinct within the cell.   
 
A. Top, Whi3 forms liquid droplets in Ashbya gossypii. Below, Whi3 droplets accumulate and fuse 
around nuclei. Green arrows denote polarity droplets. Pink arrows denote perinuclear droplets. Scale bars 
5 µm.  
 
B. Mean intensity of Whi3-tomato is higher in tip droplets (green) than perinuclear droplets (pink). 
 
C. Rate of Whi3 incorporation is higher in tip compared to perinuclear droplets.  
 
D. smFISH images show BNI1 (green) and CLN3 (pink) mRNAs are spatially distinct. Nuclei are in blue. 
Scale bar 5 µm.  
 
E. smFISH images show BNI1 (green) mRNAs co-localize with polarity mRNA SPA2 (pink). Nuclei are 
in blue. The green arrow marks where the RNAs overlap at the tip. Inset scale bar 2 µm. 
 
F. BNI1 and SPA2 are significantly more co-localized than BNI1 and CLN3. p<0.001 for tips and p<0.01 
for nuclei (Fisher’s Exact test). n= 40 nuclei and tips for ≥30 cells. 
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Figure 2. Polarity and cyclin complexes segregate in vitro.  
 
A. Experimental schematic of in vitro droplet recruitment assay.  
 
B.  CLN3 mRNA (pink) is not efficiently recruited but BNI1 or SPA2 mRNA (pink) are recruited into 
preformed Whi3-BNI1 droplets (green) based on fluorescence microscopy. Scale bar 10 µm.  
 
C. Recruitment coefficients of mRNA from B. Boxes indicate interquartile range, line is median and 
whiskers contain points within three times the interquartile range, and outliers are indicated with (•) 
marks. NS, not significant, p > 0.05; **, p < 0.01; ***, p < 0.001 (t test). n ≥500 droplets for N≥3 
biological replicates.  
 
D. Cartoon schematic and representative images showing in vitro RNA-only droplet assay where CLN3, 
BNI1, and SPA2 mRNAs assemble into liquid or gel-like droplets. Scale bar 5 µm.  
 
E. Fluorescence microscopy images showing BNI1 RNA (green) colocalizes with SPA2 RNA (pink) in 
droplets.  
 
F.  Fluorescence microscopy images showing CLN3 RNA (pink) does not colocalize with SPA2 (green) 
and BNI1 (green) droplets. Scale bar 5 µm.  
 
G. Quantification of co-localization between BNI1 and SPA2, SPA2 and CLN3, or BNI1 and CLN3 RNAs.  
NS, not significant, ***, p < 0.001 (Wilcoxon rank-sum test). n≥200 droplets for N≥3 biological 
replicates.  
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Figure 3. RNA secondary structure determines specificity and identity of Whi3-CLN3 droplets.  
 
A. Fluorescence microscopy images showing the recruitment of scrambled (cln3 scr), melted (CLN3 ml), 
and refolded CLN3 (CLN3 refold) mRNA (pink) into preformed Whi3-BNI1 droplets (green).  
 
B. Fluorescence microscopy images showing the loss of recruitment of CLN3 ml when mixed with 
oligonucleotides targeting complementary sequences of CLN3 to BNI1. Scale bar 10 µm. 
 
C. Quantification of A and B. *, p<0.05; **, p<0.01; ***, p < 0.001 (t test). n≥500 droplets for N≥3 
biological replicates.  
 
D. Base pairing probability from SHAPE-MaP of CLN3, cln3 scr, and CLN3 refold show differences in 
the secondary structure in CLN3. Arcs connect base pairs and are colored by probability. 
 
E. Secondary structure models from SHAPE-MaP for the first 400 nucleotides of CLN3, CLN3 refold, 
and cln3 scr. Whi3 binding sites are in orange.  
 
F. CLN3 structure mutant (cln3 sm) mRNA is significantly recruited to Whi3-BNI1 droplets in vitro and 
in vivo. **, p<0.01 (t test). Green arrows denote sites of co-localization between BNI1 mRNA (green) and 
cln3 sm mRNA (pink) by smFISH. Scale bar 10 µm for in vitro, 2 µm for in vivo. n ≥500 droplets for 
N≥3 biological replicates. 
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Figure 4. Whi3 binding alters RNA behavior.  
 
A. Differences in SHAPE reactivities (ΔSHAPE) were calculated by subtracting CLN3 SHAPE 
reactivities from CLN3 + Whi3 reactivities. Positive ΔSHAPE values indicate protection from 
modification in the presence of Whi3 and negative ΔSHAPE reports enhanced reactivity in the absence of 
Whi3 protein.  
 
B. Base pairing probability compared between CLN3 and CLN3 with Whi3 shows rearrangements in 
CLN3 structure in the presence of Whi3. Arcs connect base pairing sites and are colored by probability.   
 
C. Schematic of smFRET experiment.  
 
D. FRET histograms before (gray) and after (green) 0.5 or 5 µM Whi3 addition. Purple shaded regions 
denote high and mid FRET states for CLN3 and BNI1, respectively. 
 
E.  Averaged cy3 (green), cy5 (red) intensities, and representative FRET traces (blue) obtained from 
smFRET experiments of CLN3 and BNI1 in the presence of 5 µM Whi3. Dwell time analysis reveals 
slower FRET fluctuations for CLN3 than BNI1 in the presence of Whi3. 
 
F. Proposed model in which RNA-RNA interactions derived from mRNA structure promotes the 
selective uptake of distinct RNAs and protein constituents into droplets leading to distinct dynamics 
(orange zigzags) of different droplet complexes. 
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Fig. S1. Whi3, a polyQ-containing protein, forms LLPS droplets in vitro. 
 
A. Cartoon schematic of Whi3 protein sequence, in A. gossypii, depicting the disordered (polyQ, blue) 
and RNA binding domains (RRM, red).  
 
B. Whi3-BNI1 droplets (green) incorporate more Whi3 protein over time in vitro compared to Whi3-
CLN3 droplets (pink). Data are mean ± SD. n ≥ 100 droplets for N= 2 biological replicates.  
 
C. Fluorescence microscopy images showing CLN3 (pink) is excluded from Whi3-BNI1 (green) droplets 
in a variety of protein and RNA concentrations. Top, Whi3 2 µM, RNA 1.25 nM; Bottom, Whi3 20 µM, 
RNA 5 nM. Scale bar is 10 µm.  
 
D. Fluorescence microscopy images show cy3 labeled CLN3 mRNA (pink) is not efficiently 
recruited into Whi3-SPA2 droplets (green) (8 µM Whi3, 5 nM RNA) Images are representative 
of observations from three independent experiments. Scale bar is 10 µm.  
 
E. Fluorescence microscopy images showing the recruitment of cln3 scrambled mRNA (5 nM, pink) into 
droplets with Whi3 (8 µM, green). Scale bar is 10 µm.  
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Fig. S2. CLN3 and BNI1 co-assemble when regions of complementarity between the two RNAs are 
exposed through melting.  
 
A. Fluorescence microscopy images and recruitment coefficients show CLN3 mRNA (5 nM, pink) is 
modestly recruited into preformed Whi3 droplets made with melted BNI1 (8 µM Whi3, 5 nM BNI1, 
green) unless complement regions of CLN3 are also exposed through melting (CLN3 ml). In contrast, 
recruitment of CLN3 ml is lost when the mRNA is mixed with oligos targeting the sequence on CLN3 
with complementarity to BNI1 mRNA (CLN3 ml + oligos). Outliers are indicated with (•) marks. *, p < 
0.05; **, p < 0.01; ***, p < 0.001 (unpaired t test). n≥500 droplets for N≥3 biological replicates.  
 
 
B. Fluorescence microscopy images and quantification (Pearson’s correlation coefficient) show CLN3 (10 
nM, pink) RNA only droplets colocalize with BNI1 (10 nM, green) droplets only when melted (CLN3 ml) 
and recruitment is lost when the mRNA is mixed with oligos targeting the sequence on CLN3 with 
complementarity to BNI1 mRNA (CLN3 ml + oligos) Outliers are indicated with (•) marks. *, p<0.05, **, 
p < 0.01; ***, p < 0.001 as determined by Wilcoxon rank-sum test. n≥200 droplets for N≥3 biological 
replicates.  
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Fig. S3. CLN3 mRNA secondary structure is altered when the mRNA sequence is 
scrambled or refolded. 
 
A. SHAPE reactivity profiles for CLN3 and CLN3 refolded. High values indicate unstructured regions or 
many possible structures, while low values suggest a single well-defined structure. Data are mean ± SD 
 
B. SHAPE reactivity profiles for cln3 scr indicates it has a completely different secondary structure than 
CLN3 native sequence. Data are mean ± SD. 
 
C. SHAPE reactivity and Shannon entropy values for the first 400 nucleotides of the RNAs 
shown as the median reactivity smoothed over a 19-nt sliding window relative to the global 
median. Reactivity values for CLN3 in this region are significantly lower than reactivity values for CLN3 
refolded (median of 0.19 vs 0.32 respectively; Wilcoxon rank sum test, p = 0.001), suggesting that the 
CLN3 refolded mRNA contains less well-defined structures. Purple shaded regions show 
low-SHAPE/low-entropy regions. These regions transition to high-SHAPE/high-entropy regions 
when the CLN3 sequence is melted and refolded. 
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Fig. S4. Regions of Complementarity between CLN3 and BNI1.  
 
 
A. Cartoon schematic of CLN3 and BNI1 RNA depicting the location of Whi3 binding sites (orange) and 
the regions of complementarity (numbered) between the two RNAs. RNAs are drawn to scale.  
 
B. Shape reactivity and arc plots for the five regions along CLN3 that can base-pair with BNI1 and 
regions on BNI1 that can base pair with CLN3. The blue shaded regions indicate the exact complement 
sequence. Most of these regions on both CLN3 and BNI1 are located in low SHAPE, high structured 
regions, indicating that these regions are likely not exposed and unable to interact when properly folded. 
The median SHAPE reactivity per region is displayed above its respective region. Data are mean ± SD. 
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Fig. S5. CLN3 mRNA secondary structure is altered with point mutations to target stem loops.  
 
A. Shape reactivity profiles for CLN3 structure mutant (cln3 sm). High values indicate unstructured 
regions or many possible structures, while low values suggest a single well-defined structure. Data are 
mean ± SD. 
 
B. Base pairing probability compared among CLN3 and cln3 sm show differences in the secondary 
structure between the two mRNAs. Arcs connect base pairs and are color coded by probability.   
 
C. Secondary structure models for the first 400 nucleotides of CLN3 and cln3 sm. Whi3 binding sites are 
denoted in orange. The sequence targeted for mutation in cln3 sm is denoted in purple. 
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Fig. S6. Regions of complementarity between BNI1 and SPA2.  
 
 
A. Cartoon schematic of BNI1 and SPA2 RNA depicting the location of Whi3 binding sites (orange) and 
the regions of complementarity between the two RNAs. RNAs are drawn to scale. 
 
B. Shape reactivity and arc plots for the five regions along BNI1 that can base-pair with SPA2 and regions 
on SPA2 that can base pair with BNI1. The blue shaded regions indicate the exact complement sequence. 
Most of these regions are located in high SHAPE, low structured regions, indicating that these regions are 
likely exposed and able to interact. The median SHAPE reactivity per region is displayed above its 
respective region. Data are mean ± SD. 
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Fig. S7. Disruption of regions of complementarity interferes with coassembly between two RNAs. 
 
A. Fluorescence microscopy images and quantification show SPA2 mRNA incubated with oligos to target 
the complement nucleotide regions of BNI1 (5 nM, pink) is less recruited into preformed Whi3-BNI1 
droplets (8 µM Whi3, 5 nM BNI1, green) compared to native SPA2 alone.  The line at the center of the 
box indicates the median value, and boxes indicate interquartile range. Whiskers contain data points 
within 3 times the interquartile range, and outliers are indicated with (•) marks. *, p < 0.05 (unpaired t 
test). Scale bar is 10 µm. n≥500 droplets for N≥ 3 biological replicates.  
 
B. Fluorescence microscopy images and quantification (Pearson’s correlation coefficient) showing SPA2 
mRNA (10 nM, pink) incubated with oligos to target the complement nucleotide regions to BNI1 (5 nM, 
pink) are excluded from BNI1 mRNA (10 nM, green) in the presence of Spermine. ***, p < 0.001 
(Wilcoxon rank-sum test). Scale bar is 5 µm. n≥200 droplets for N≥ 3 biological replicates. 
 
C. Single molecule mRNA FISH images show that a codon randomized CLN3 (cln3 codon, green) 
mRNA does not co-localize with endogenous CLN3 mRNA (pink) in vivo. Scale bar is 5 µm.  
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Fig. S8. Whi3 binding sites are located in highly structured region along BNI1 mRNA.   
 
A. Cartoon schematic of BNI1 RNA depicting the location of the five Whi3 binding sites (orange). RNA 
is drawn to scale. 
 
B.  Secondary structure plots show regions of BNI1 mRNA surrounding Whi3 binding sites.  
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Fig. S9. The majority of Whi3 binding sites are located in highly structured region along SPA2 
mRNA.   
 
A. Cartoon schematic of SPA2 RNA depicting the location of the eleven Whi3 binding sites (orange). 
RNA is drawn to scale. 
 
B.  Secondary structure plots show regions of SPA2 mRNA surrounding Whi3 binding sites.  
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Fig. S10. Whi3 binding is essential to induce dynamic fluctuations to its target mRNAs, CLN3 and 
BNI1.  
 
A. Shape reactivity profiles for CLN3 and CLN3 in the presence of Whi3 protein. High values indicate 
unstructured regions and many possible structures, while low values suggest a single well-defined 
structure. The four Whi3 binding sites (WBS) are shaded in purple and show the differences in SHAPE 
reactivity along CLN3 in the presence or absence of Whi3. Data are mean ± SD. 
 
B. FRET histograms show RNA only (gray) or addition of Whi3 (green) or a Whi3 RNA binding mutant 
(whi3-Y610-F653A, orange).  
 
C. The mutant exhibits much lower dynamics with both CLN3 and BNI1 indicating that Whi3 binding is 
needed to induce dynamic fluctuations to the two RNAs.  
Materials and Methods 
 
Plasmid and Strain Construction 
To create pcln3sm::GEN; cln3D::NAT1 construct, under the control of its own promoter, 
the entire plasmid AGB237 (pCLN3- GFP::GEN3, AMP) was amplified using primers Phusion 
polymerase (New England Biolabs) and AGO2308 (GGGCTGTTA 
ATATCTCATACCCGTTGTGGTTTGCATATTATACACATATTCG) and AGO2309 
(CGAATATGTGTATAATATGCAAACCACAACGGGTATGAGATATTAACAGCCC).  This 
mutated a region 31 base pairs upstream of the ORF from AACACC to TTGTGG.  The reaction 
was digested with DpnI (New England Biolabs).  The 5’UTR, ORF, and 3’UTR were sequenced 
by Genewiz, confirming that TTGTGG was the only mutation.  This plasmid was transformed 
into A. gossypii AG612 (cln3Δ::NAT1) via electroporation and selection on AFM+G418 plates. 
To create pcln3sm::GEN under control of a T7 promoter, the entire plasmid AGB690 
(CLN3-GFP) was amplified with the primers AGO2308 and AGO 2309 using the QuickChange 
XL Site-Directed Mutagenesis kit (Agilent Technologies) following the instructions.  The 
5’UTR, ORF, and 3’UTR were sequenced by Genewiz, confirming that TTGTGG was the only 
mutation.  This plasmid was then digested and used as a template to transcribe RNA using the T7 
HiScribe in vitro transcription kit (NEB). 
To create the pcln3scr2; DlDt a geneblock containing the scrambled coding sequence for 
CLN3 was ordered from GenScript and amplified with primers 5’ TAAACGAAG 
GCAAAGAGCTCGGTACCCGGGGACGTTCACTAATCTTAATACG 3’ and 
5’GTGAAAAGTTCTTCTCCTTTACTCATCTCAGTACGCGGCCGCTCGAGAGATCTTGT
AATTAATCCTGC 3’. AGB392, a plasmid containing GFP under the control of the S. 
cerevisiae HIS3 promoter, was cut with BamHI and SpeI restriction enzymes to linearize the 
plasmid. The CLN3 scr2 amplified coding sequence was cloned into the cut AGB392 vector 
using NEBuilder HiFi DNA Assembly (New England Biolabs). Cloning was confirmed via 
sequencing (Genewiz) using 5’ TGGTTATGGCGCCCTCACAG 3’ and 5’ 
GCCCATTAACATCACCATCTAATTC 3’.  This plasmid was transformed into WT A. gossypii 
(AG416) via electroporation and selection on AFM+G418 plates. 
 
Cell culture and Imaging 
 
Ashbya cells were grown in 10 mL Ashbya full media (AFM) under selection of either G418 (200 
ug/ml) or Clonat (100 ug/ml) in a 125 ml baffled flask shaking at 30°C for 16 hours. The cultures 
were then transferred to 15 ml conical tubes (VWR) for centrifugation at 350 rpm for 2 min. AFM 
was removed and cells were suspended in 10 ml 2X Low Fluorescence media. Cells were then 
placed on a 2X Low Fluorescence media gel-pad containing 1% agarose embedded in a depression 
slides, sealed with valap and imaged. For dye incorporation experiments, Ashbya cells encoding a 
Whi3 HaloTag were spun down, washed with 2X Low Fluorescence Media and then incubated 
with 62.5 nM JF649 Halo dye (Lavis Lab, Janelia Farms Research Campus) for 20 min. The cells 
were then washed twice before being placed on gel pads and imaged at indicated time intervals. 
Image intensity for each droplet was quantified by finding the highest intensity pixel within the 
droplet and then taking the average intensity of a circle of about 9 pixels around the highest 
intensity pixel.  All image processing and analysis for in vivo experiments was carried out in either 
Fiji or MATLAB (19, 20). For Whi3-tomato measurements, N=2 independent experiments with 
n=4 cells, 73 perinuclear droplets and 27 tip droplets were measured and for Whi3-Halo, N=2 
independent experiments n=7 cells, 40 perinuclear droplets and 15 tip droplets were measured.  
 Single molecule RNA F.I.S.H and Imaging 
 
RNA smFISH labeling was performed as previously described (12). Briefly, cells were grown 
overnight at 30 °C in AFM and were fixed using 3.7% (vol/vol) formaldehyde (Fisher Scientific) 
and then washed twice with cold buffer B. Cells were resuspended in 1mL of spheroplasting buffer 
and digested using 1.5 mg/ml Zymolyase (MP Biomedicals) for 30 min at 37 °C. Cells were 
washed twice with buffer B, and then treated with Proteinase K for 5 min to digest proteins and 
unmask protein-bound RNAs. Cells were then washed twice before being resuspended in 70% 
ethanol, and incubated overnight at 4 °C. Cells were washed twice with SSC wash buffer before 
being resuspended in hybridization buffer containing Tetraethyl rhodamine (TAMARA) or cy5-
conjugated RNA FISH probes (Stellaris LGC Biosearch Technologies) complementary to each 
transcript of interest. Cells were incubated in the dark overnight at 37 °C. After incubation, cells 
were washed once with wash buffer, incubated with 5 ug/ml Hoechst (Invitrogen) and incubated 
at room temperature for 30 min before being washed a final time with wash buffer, mounted on 
glass slides with 20 ul Prolong Gold mounting medium (Invitrogen), sealed with nail polish, and 
then imaged. Images were de-convolved using 29 iterations of the Lucy-Richardson algorithm on 
Nikon Elements software and then processed in Fiji.  
 
Analysis of mRNA fraction co-localized 
 
A 8 X 10 ROI was generated at the tips of hyphae or around individual nuclei in merged images. 
Percent of co-localization was determined by counting the presence of overlapping signal from 
each of the individual mRNA channels. A total of 40 tips and nuclei were used for analysis and 
taken across at least 2 biological replicates. mRNAs inside the nucleus were counted and co-
localization events inside the nucleus were counted as well.  
 
Recombinant Protein Expression and Purification  
 
Protein purification was performed as previously described (3). In brief, full length Whi3 or whi3-
Y610-F653A was tagged with an N-terminal 6-Histidine tag and expressed in BL21 E. coli (New 
England Biolabs). For labeled protein, full length Whi3 was tagged with a C-terminal GFP. Cells 
were lysed in lysis buffer (1.5M KCl, 20 mM Tris pH 8.0, 20 mM Imidazole pH 8, 1 mM DTT, 1 
tablet of Roche protease inhibitor cocktail). The supernatant was incubated and passed over a Ni-
NTA resin (Qiagen) in gravity columns. The resin was then washed with 10CV lysis buffer and 
protein was eluted with 6CV elution buffer (150 mM KCl, 20 mM Tris pH 8.0, 200 mM Imidazole 
pH 8.0,1 mM DTT). The fractions containing Whi3 protein were dialyzed into fresh droplet buffer 
(150 mM KCl, 20 mM Tris pH 8.0, 1 mM DTT) and measured with Bradford reagent. Aliquots of 
protein were flash frozen and stored at -80 ºC.  
 
RNA Transcription 
 
The T7 promoter 5’ TAATACGACTCACTATAGGG 3’ was cloned into the 5’ end of CLN3 
(AGB 690), BNI1 (AGB 691), and SPA2 (AGB 692). The cln3-scr plasmid was synthesized with 
the T7 promoter (IDT). Plasmid DNA was digested with restriction enzymes to obtain a linear 
DNA template that was then transcribed using T7 Hiscribe in vitro transcription kit (NEB) 
according to manufacturer’s instructions. To obtain labeled RNA for imaging, 0.1 ul of 5 mM cy3-
UTP or cy5-UTP (GE Healthcare) was added into the transcription reaction. Transcribed RNAs 
were then treated with DNase, precipitated with LiCl, and washed with 85% ethanol before being 
re-suspended in TE buffer and stored at -80 ºC. 
 
Droplet Assembly and Imaging 
 
Whi3 used in experiments contain 10:1 unlabeled to GFP-labeled protein. For recruitment 
experiments, Whi3 protein and cy5 labeled BNI1 RNA were mixed and incubated for four hours 
in glass chambers (Grace Bio-Labs) at room temperature to desired concentrations in droplet 
buffer. The chambers were pre-treated with 30 mg/mL BSA (Sigma) for 30 minutes. After four 
hours, cy3-labeled RNA of interest was added to the wells, mixed, and incubated for 30 min. 
Imaging of droplets was done either on a spinning disc confocal microscope (Nikon CSU-W1) 
with VC Plan Apo 60X/1.49 NA oil immersion objective and an sCMOS 85% QE camera 
(Photometrics) or a custom spinning disk confocal microscope (Nikon Ti-Eclipse equipped with a 
Yokogawa CSU-X spinning disk module) using a 60X 1.49 NA oil immersion objective and an 
air-cooled EM-CCD camera. For the RNA melting experiments, RNA was denatured at 95 ºC for 
three minutes and then immediately added to preformed droplets. For the RNA refolding 
experiments, RNA was denatured at 95 ºC for three minutes and then cooled down at 1-4 ºC per 
minute to 37 ºC final temperature in a thermocycler, added to preformed droplets, and imaged 
immediately. For the BNI1 melted experiments, BNI1 mRNA was heated to 95 ºC for 3 minutes 
before being mixed with Whi3 and incubated for 2 hours. CLN3 mRNA was then added and 
immediately imaged. For the CLN3 oligonucleotide experiments, 5 nM CLN3 was mixed with a 
100 nM mixture of the 5 oligo nucleotides (Supplemental Table 2). This mixture was then melted 
to 95 ºC for 5 min then cooled to 70 ºC (average melting temperature for the 5 oligos) for 10 min 
in a thermocycler before being added to BNI1 droplets and imaged. For the SPA2 oligonucleotide 
experiments, 5 nM of SPA2 was mixed with a 100 nM mixture of the 4 oligo nucleotides 
(Supplemental Table 2). This mixture was then incubated at 25 ºC for 10 min in a thermocycler 
before being added to BNI1 droplets and imaged. At least five independent imaging areas were 
analyzed for each condition for each replicate. Data shown are representative of three or more 
independent replicates, across at least two RNA and protein preparations.  
 
 
 
RNA Spermine experiments and analysis 
 
For RNA spermine experiments, 10 nM in vitro transcribed mRNAs were incubated for 4 hours in 
Spermine buffer (10 mM Spermine tetrahydrochlroide (Sigma), 20 mM KCl, 10 mM MgCl2) as 
previously described (14) and then imaged on a custom spinning disk confocal microscope (Nikon 
Ti-Eclipse equipped with a Yokogawa CSU-X spinning disk module) using a 60X 1.49 NA oil 
immersion objective and an air-cooled EM-CCD camera. For the RNA melting experiments, both 
BNI1 and CLN3 were melted for 3 minutes at 95 ºC before being mixed together and incubated for 
four hours.  For the CLN3 oligonucleotide experiments, 10 nM CLN3 was mixed with a 100 nM 
mixture of the 5 oligo nucleotides. This mixture was then melted to 95 ºC for 5 min then cooled to 
70 ºC for 10 min in a thermocycler before being added to wells to incubate for four hours. For the 
SPA2 oligonucleotide experiments, 10 nM of SPA2 was mixed with a 100 nM mixture of the 4 
oligo nucleotides. This mixture was then incubated at 25 ºC for 10 min in a thermocycler before 
being added to wells to incubate for four hours. Images were cropped to the middle 11 z stacks. 
Cy3 and cy5 channels, representing the different RNAs, were split and each channel was 
background subtracted with a 100-pixel rolling ball. Data shown are representative of three or 
more independent replicates, across at least two RNA preparations. The ImageJ plugin “JACoP” 
(https://imagej.nih.gov/ij/plugins/track/jacop.html) was used to calculate the Pearson’s Correlation 
Coefficient between the two background-subtracted channels. The Wilcoxon Rank Sum Test was 
used to test for statistical significance between experimental conditions. 
 
The DNA oligonucleotide sequences (IDT) used are as follows. 
CLN3 to BNI1:  
        30 mer 461-479:   5’tcaaagTGCGCATCTCCACGGTAAGttccg 3’ 
        30 mer 748-758:   5’cagagcacaCAGACCAGTTAaggctcttga 3’ 
        30 mer 969-992:   5’ctaTGAACTCGGAGAGCTCAGCGAGTCgga3’ 
        30 mer 1225-1248:  5’gcaCTGTCCGGTGCtGAGCCTGCACATggc 3’ 
SPA2 to BNI1:  
30 mer 55-85:   5’ GGGTCGAGCTTagacctgggcgcaggcatt 3’ 
 30 mer 1266-1296:  5’ gtcgaaAGTGATGATATCAACAGaggatgg 3’ 
 30 mer 4173-4203:  5’tcgggcTGCTTCTCCAGGATCATtggtgtc  3’ 
 30 mer 4294-4324:  5’ tcgcctTTTAATTTTGAGACTTCatcaggg 3’ 
 30 mer 10018-10048:  5’ tcgaatataAGCCGCACCGCCtcccactct 3’ 
 
Analysis of RNA Recruitment 
 We calculated a Recruitment Coefficient (RC) for RNAs added into preformed Whi3-BNI1 
droplets which is defined by the following equation:  
 
 
where RC is the recruitment coefficient, [RNA]PD is the concentration of added RNA (cy3) within 
the preformed droplets, [RNA]O is the concentration of added RNA (cy3) outside the preformed 
droplets. A higher RC indicates that the RNA is more concentrated in preformed droplets. All 
image analysis was performed using Fiji. To obtain the concentration of RNA, image channels 
were split into preformed droplets (cy5) and added RNA (cy3). A mask was created on the 
preformed droplet channel after background subtraction. Droplets were identified using the 3D 
objects Counter plugin, with intensity threshold of 1480 for data acquired on the Yokogawa CSU-
X and 100 for data acquired on the Nikon CSU-W1. This method was used to obtain the integrated 
density of the cy3 channel and the area of the preformed droplets. Average mean fluorescent 
intensity (MFI) of preformed droplets was then calculated as the sum of integrated density across 
the z-stack volume divided by sum of area across the z-stack volume. Then, per z-stack volume, 
inverse selection of preformed droplets is measured for integrated density and area. Average MFI 
outside preformed droplets calculated as above. MFI values are converted to dye concentration 
using linear fit of a concentration curve of cy3 dye (one for each instrument). RNA concentrations 
were obtained by normalizing the dye concentration by the average number of dye molecules 
incorporated into each different RNA. To calculate significance between different RNAs, unpaired 
t tests were performed on log-transformed RC values between experimental conditions in R 
version 3.4 (21).  
 Analysis of Whi3 to RNA ratios 
 
Whi3-RNA droplets were imaged, as previously described, over the course of four hours, starting 
thirty minutes after the addition of the RNA to Whi3. Image analysis was performed in Fiji. For 
each time point, the RNA and Whi3 channels were split, background subtracted, and 3D object 
counter was used to measure the MFI of both RNA and Whi3 channels separately. MFI values for 
RNA and Whi3 were then converted to concentrations based on a linear GFP or RNA dye curve. 
Whi3 concentrations were corrected for the unlabeled protein present. For each time point, the 
average concentration was calculated and then the ratio of Whi3 to RNA was calculated as the 
average Whi3 concentration divided by the average RNA concentration. The standard deviation 
of the ratio was calculated based on the following equation: 
 
 
 
where Whi3 is the concentration of Whi3, RNA is the concentration of RNA, Var(x) is the variance 
of variable x, and Cov (x, y) is the covariance of variables x and y. 
 
SHAPE-MaP experiments and Analysis 
 
SHAPE-MaP was performed as previously described (15). In brief, 500 ng of in vitro transcribed 
RNA was added to one-ninth volume of 1M7 or neat DMSO (10 mM final concentration) and 
incubated at room temperature for 10 minutes. RNAs were exchanged into TE buffer (10 mM 
Tris-HCl, 1 mM EDTA) (Ambion) using a desalting column (GE Life Sciences). For CLN3, 
CLN3 refolded, cln3 scr, cln3 sm, BNI1 and SPA2 mRNAs, modified (1M7) and untreated 
(DMSO) RNAs were subjected to mutational profiling (MaP) reverse transcription with a 
random primer (200 ng/ ul R9, NEB). The resulting cDNA was purified (Agencourt RNACLean 
XP beads, Beckman Coulter) and prepared for library construction by second strand synthesis 
module (NEB). These cDNAs were then used in amplicon library preparation using Nextera XT 
indices 1 and 2 and tagmentation and PCR protocol. CLN3 that was modified with 1M7 or 
incubated with DMSO in the presence of Whi3 protein (2 uM Whi3, 27 nM CLN3), was heated 
to 95 °C to denature the proteins and RNA was recovered and purified with RNAClean XP 
beads. The RNAs were subjected to mutational profiling (MaP) reverse transcription with a gene 
specific primer (5’ CGGCTGGGACTGGAAGC 3’; IDT) to amplify the first 500 nucleotides of 
the mRNA. Sequencing libraries were created with CLN3 and Whi3 + CLN3 amplicons using 
IDT gene specific primers F1 (5’ GACTGGAGTTCAGACGTGTGCTCTTCCGATCT 
NNNNNGTCTGCATACCAAGGATCAGC 3’) and R1 ( 5’ 
CCCTACACGACGCTCTTCCGATCTNNNNNCGGCTGGGACTGGAAGC 3’). Libraries 
were purified using DNA beads (Agencourt) and sequencing libraries were pooled and then 
sequenced on an Illumina MiSeq instrument. SHAPE reactivity profiles were created by aligning 
the RNA reference sequence using ShapeMapper v 0.15 (www.chem.unc.edu/rna/software.html). 
Default parameters were used and the folding module was not used. RNA structural modeling 
was created by Superfold with 1M7 reactivities under default parameters and deltaSHAPE was 
calculated and plotted using deltaSHAPE software (www.chem.unc.edu/rna/software.html). 
RNA secondary structure arc plots were drawn with recently developed tools implemented in the 
Integrative Genomics Viewer (22). 
 
Median read depths are reported in Table S1. 
  
 
 
 
 
 
 
 
 
 
 
 
Table S1. Median read depth for modified and untreated SHAPE-MaP experiments. 
 
Single Molecule FRET experiments and Analysis. 
A custom-built total internal reflection fluorescence (TIRF) microscope was used for all single 
molecule fluorescence assays. Lasers of different wavelengths were used to excite different 
fluorescent dyes. For FRET experiments involving Cy3 (donor) and Cy5 (acceptor) dyes, a solid 
state 532nm laser (75mW, Coherent CUBE) was used to excite the donor dye. For the counting of 
GFP photobleaching steps, a 488nm laser (50mW, Coherent Sapphire) was used. For FRET 
imaging, the emitted signals were separated by dichroic mirrors with a wavelength cutoff of 630nm 
to separate the Cy3 and Cy5 emissions. The signals were then detected by an EMCCD camera 
(iXon DU-897ECS0-#BV; Andor Technology). The camera was controlled via a custom C++ 
program, and single molecule traces extracted recorded data using IDL software. Single molecule 
traces were then displayed and analyzed using Matlab and Origin software. All code can be found 
in the single molecule FRET (smFRET) package available at the Center for the Physics of Living 
RNA Modified read depth Untreated read depth 
CLN3 88,775 31,645 
CLN3 refold 15,989 15,380 
cln3 scr 38,418 32,906 
cln3 sm 101,590 98,472 
BNI1 27,147 38,362 
SPA2 20,936 9,314 
CLN3 (amplicon) 233,978 219,741 
CLN3 + WHI3 (amplicon) 37, 236 128,531 
Cells (https://cplc.illinois.edu/software/, Biophysics Department, University of Illinois at Urbana-
Champaign). 
 
RNA substrate prep 
 
Single strand RNAs were ordered from Integrated DNA Technologies (Coralville, IA, USA) 
containing amino modifier at the labeling site. The RNAs were labeled using Cy3/Cy5 
monofunctional NHS esters (GE Healthcare, Princeton, NJ, USA). Then, 10 nmol of amino 
modified oligonucleotides in 50 ml of ddH2O and 100 nmol of Cy3/Cy5 NHS ester dissolved in 
DMSO was added and incubated with rotation overnight at room temperature in the dark. The 
labeled oligonucleotides were purified by ethanol precipitation. 
 
For FRET experiments, CLN3 and BNI1 FRET RNA partial duplex RNA substrates were 
composed of dsRNA consisting of 18 bps of random CG-rich sequences and ssRNA consisting of 
truncated versions of CLN3 or BNI1 RNA. A Cy5-Cy3 FRET pair was placed at the junction and 
the 3’ end of the ssRNA, respectively (Fig. 4C).  
 
The RNA sequences used are as follows. 
18mer for CLN3: 5’ – Biotin – UGG CGA CGG CAG CGA GGC – Cy5 – 3’ 
CLN3 RNA: 5’ – Cy3 – UAC CUG CAC GCG GUC GAG ACG UCU GCA UAC CAA GGA 
UCA GCC GCU UGC AUU AAA GGG GAC GAA CCG GGG C GCC UCG CUG 
CCG UCG CCA – 3’ 
18mer for BNI1: 5' – Biotin – ACC GCU GCC GUC GCU CCG – Cy5 – 3' 
RNA: 5’ – Cy3 – AUA UUC UAC AUG AUU AUG AUG CAU UAG AGA AGG AAA ACG 
CCU ACU AUA AGU GUU UGA GAG UCC AUA UUC UAC AUG AU CGG AGC 
GAC GGC AGC GGU – 3’ 
 
RNA substrates were annealed by mixing the biotinylated and non-biotinylated oligonucleotides 
in a 1:2 molar ratio in T50 buffer (50mM NaCl, 10mM Tris-HCl (pH 8.0)). The final concentration 
of the mixture was 10uM. The mixture was then incubated at 95°C for 2 minutes followed by slow 
cooling to room temperature to complete the annealing reaction in just under two hours. The 
annealed RNAs were diluted to 10nM single molecule stock concentration and stored at -20°C. 
 
All experiments were performed in Whi3 Reaction Buffer (150mM KCl, 50mM Tris-HCl (pH 
8.0), 1mM DTT) with an oxygen scavenging system containing 0.8% v/v dextrose, 1 mg/ml 
glucose oxidase, 0.03 mg/ml catalase1, and 10mM Trolox. All chemicals were purchased from 
Sigma Aldrich (St. Louis, MO). The experiments were all performed at room temperature. Fifty 
to 100pM of biotinylated FRET RNA were immobilized on polyethylene glycol (PEG)-coated 
quartz surface via biotin-neutravidin linkage.  
 
Whi3-RNA FRET experiment 
 
Whi3 proteins were prepared as described above. Then, 0.5 to 5uM of Whi3 or whi3-Y610-F653A 
proteins in droplet buffer was added to immobilized RNA substrates, and 10-20 short movies (10 
seconds) and 3-4 long movies (2 minutes) were then taken to monitor the Cy3 and Cy5 emission 
intensities over time. These are then analyzed to produce the FRET histograms and trajectories 
shown in Fig. 4D.  
 
Dip-to-dip FRET fluctuation dwell times were collected between each successive dip in the FRET 
trace. These time intervals were then fitted to a single exponential decay function using Origin 
(OriginLab Corporation, Northampton, MA) to extract the half-life for each protein-RNA 
combination.  
 
